GDF-15 represents a promising target both for the reversal of cancer cachexia and for the enhancement of an antitumor response, however, additional research is needed to further elucidate its potential either as a single therapy or in combination with existing immunotherapies. This evidence concerns the gene GDF15 and cancer.